Revolution Medicines Inc

NASDAQ: RVMD
$38.44
+$0.23 (+0.6%)
Real Time Data Delayed 15 Min.

RVMD Chart and Intraday Price

RVMD Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 700 SAGINAW DR, REDWOOD CITY, CA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 4,907.76M USD
Shares Outstanding 164,690,000
Revolution Medicines is a pioneering biotech firm focused on creating innovative treatments for cancers driven by RAS mutations. With a robust pipeline of novel targeted therapies, the company is at the forefront of precision oncology. Its leading candidates, including RMC-6236, RMC-6291, and RMC-9805, are undergoing clinical trials to tackle various RAS-addicted cancers. Additionally, Revolution Medicines is exploring combination treatments to enhance efficacy. Founded in 2014 and based in Redwood City, California, the company is dedicated to transforming cancer treatment paradigms.

RVMD Articles

Wednesday's top analyst upgrades and downgrades included Broadcom, Clean Energy Fuels, Dish Network, First Republic Bank, Gaming and Leisure Properties, Occidental Petroleum, Revolution Medicines,...
Friday's top analyst upgrades and downgrades included AT&T, Exxon Mobil, Hasbro, Juniper Networks, Moderna, Palo Alto Networks, Snap, Teva Pharmaceutical, Under Armour and Zscaler.
Monday's top analyst upgrades, downgrades and initiations included American Express, ADT, Gilead Sciences, Logitech, PACCAR, Regions Financial, Stamps.com and Vivint Smart Home.